Compare Cytokinetics Inc (CYTK) vs HSBC Holdings plc (HSBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs HSBC Holdings plc — how do they compare? Cytokinetics Inc trades at $77 (market cap $10.63B), while HSBC Holdings plc trades at $103.88 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 33.3× Cytokinetics Inc's market cap, and HSBC Holdings plc pays a 3.63% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | HSBC | |
|---|---|---|
Market Cap | $10.63B | $353.82B |
Sector | Technology | Technology |
52-Week High | $87.26 | $107.86 |
52-Week Low | $34.31 | $63.84 |
Enterprise Value | $10.74B | — |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →
